Refine by
Miradx Patient Selection Equipment & Supplies
1 equipment items found
Manufactured by:MiraDx based inLos Angeles, CALIFORNIA (USA)
MiraDx discovered a panel of such mutations that predict both response and toxicity to anti-PD1 and anti-PDL1 therapies currently on the market. We are working with potential partners to incorporate these findings into the newer agents to allow better patients selection to achieve improved response and less toxicity from these exciting new therapies. We are ...